DIGESTIVE DRUGS MARKET ANALYSIS

Digestive Drugs Market, By Type (Branded and Generic), By Drug Class (5-aminosalicylates, GI stimulants, Laxatives, Antacids, H2 Antagonists, Antidiarrheals, Others), By Route of Administration (Oral, Intravenous, Others), By Application (Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome, Ulcerative Colitis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Feb 2023
Code : CMI5542
Pages :250
Formats :
Excel and PDF
Industry : Pharmaceutical

Digestive Drugs MarketSize and Trends

Global digestive drugs market is estimated to be valued at US$ 52,594.8 million in 2022 and is expected to exhibit a CAGR of 5.86% during the forecast period (2022-2030).

Increasing prevalence of gastrointestinal disorders is expected to propel the market growth over the forecast period.

The increasing prevalence of gastrointestinal disorders is expected to boost the market growth over the forecast period. For instance, according an article published in July 2022, by the International Foundation for Gastrointestinal Disorders, Inc. (IFFGD), the prevalence in 2014 of Gastroesophageal Reflux Disease (GERD) in global populations is around 18 to 28% in North America, 9 to 26% in Europe, 9 to 33% in Middle East and 3 to 8% in East Asia among others.

Digestive Drugs Market Report Snapshots